Psychedelics Today, Author at PsyNews.com

Home Authors Posts by admin

2176 POSTS 0 COMMENTS

https://psynews.com

PT452 – Metaplasticity, Reopening Critical Periods, and Octopuses on MDMA

How To Get Your Start as a Psychedelic Informed Practitioner

PT451 – ALPS Conference 2023: A Window Into Switzerland’s Psychedelic Scene

PT450 – Dreams, Psychedelics, Symbolism, and Cockroaches

Natural Medicine Advisory Bulletin #4: September 2023

PT449 – “Fantastic Fungi” and “Gratitude Revealed”: How Psychedelics Inspired a...

Introducing the Psychedelic News Feed

atai Life Sciences to Participate in the Jefferies Inaugural Biotech CNS/Neuro...

PT448 – Ibogaine, Noribogaine, and the Challenges of Federal Drug Policy

Clearmind Medicine to Present at the 8th Annual Dawson James Conference...

1...414243...218 Page 42 of 218

EDITOR PICKS

‘No Prejudice, No Hype’: Florence Butlen-Ducuing on Europe’s Psychedelic Renaissance

August 2025 Psychedelic Patent Update

Unpacking FDA’s MDMA Rejection Letter and the Road Ahead for Lykos

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

ABOUT US

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

admin